Mercurna is a biotech company delivering messenger RNA (mRNA) based medicines. It offers a platform technology that combines cell-targeting ligands with a proprietary lipid-based delivery vehicle in order to deliver engineered mRNA to the diseased tissues. The company specializes in providing precision medicines for eye disease, gum disease, chronic kidney disease, sepsis, and skin and lung diseases.